BAL transcriptomics identifies three proposed pneumonia lung phenotypes

The commentary discusses findings from transcriptomic analysis of bronchoalveolar lavage (BAL) cells across four cohorts of patients with severe pneumonia. The analysis identified three pulmonary profiles: an “immunologically silent” phenotype with few alveolar neutrophils, a balanced inflammatory phenotype, and a hyperinflammatory phenotype enriched for immature neutrophils. These profiles were not detectable in blood. The authors report that outcomes were best in the balanced phenotype, which had the fastest time to ventilator liberation and the lowest mortality; the least inflamed lung phenotype combined with a more inflammatory blood signature was associated with the worst outcomes.

The authors propose mechanisms including impaired surfactant processing in the low-inflammation phenotype and self-sustaining inflammatory cycles in the hyperinflammatory phenotype. They suggest that IL-6 receptor antagonism could merit investigation for the latter, but this is a proposed therapeutic direction, not evidence of treatment benefit. The work is a commentary on prior cohort analyses, and the phenotypes are not ready for routine use. Translation will require a clinically practical classifier, studies of phenotype stability over time, and trials testing stratified therapies.